Partex.AI
Partex.AI is a Germany-based AI drug-asset company that finds new uses for deprioritised drug candidates. It in-licenses and develops such assets itself and helps pharma and biotech companies license theirs, using its Ontosight AI platform.
Analytics date: 13.11.2026
Basic information
Head office
Frankfurter Strasse 27, 65760 Eschborn, GermanyHead officeGeography of business
Germany- United States of America
- India
- Switzerland
- Singapore
- United Arab Emirates
Geography of business
Analytics date: 13.11.2026
IPO Forecast
Partex.AI has not announced any plans for an initial public offering. The company remains privately held; since 2022, a majority stake has been held by Avaloq founder Francisco Fernandez, as reported by Bilanz.
Request price
Competitor Analysis
Comparison with other companies in the industry.
| Name | Valuation |
| Private companies | |
Noom | 00000 |
Zocdoc | 0000 |
LetsGetChecked | 000 |
Everlywell | 0000 |
AI21 Labs | 00000 |
| Traded companies | |
CVS Health Corporation | 000 |
Gojek | 000 |
Quest Diagnostics | 000 |
Labcorp | 00000 |
Lantern Pharma | 00000 |
| Acquired companies | |
xAI | 00 |